Potential medicines to treat COVID-19

evaluated the efficacy and safety of remdesivir for the treatment of COVID-19. Two placebo-controlled RCTs (n=1300) and two case series (n=88) were included – one of which is the Wang et al study (Ref 31). All studies used remdesivir 200mg IV the first day and 100mg IV … ................
................